NPI: 1902870298 · ESCONDIDO, CA 92025 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/14/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/14/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| DVA RENAL HEALTHCARE INC | SELLS | AZ | $7.17M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 27,969 | $3.27M |
| 2019 | 24,847 | $1.85M |
| 2020 | 15,014 | $1.00M |
| 2021 | 13,761 | $1.04M |
| 2022 | 11,809 | $1.04M |
| 2023 | 10,795 | $1.28M |
| 2024 | 10,625 | $1.45M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 49,601 | 5,010 | $10.70M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 27,856 | 2,336 | $125K |
| J1756 | Injection, iron sucrose, 1 mg | 8,789 | 2,618 | $32K |
| J1270 | Injection, doxercalciferol, 1 mcg | 14,725 | 1,723 | $25K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,269 | 764 | $22K |
| A4657 | Syringe, with or without needle, each | 3,042 | 1,785 | $20K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 313 | 239 | $7K |
| 83970 | 963 | 932 | $2K | |
| 82728 | 854 | 817 | $2K | |
| 0250 | 2,030 | 139 | $2K | |
| 82108 | 266 | 259 | $849.26 | |
| 83550 | 816 | 779 | $453.67 | |
| 83540 | 897 | 860 | $336.35 | |
| 85041 | 1,142 | 1,086 | $209.60 | |
| 85045 | 166 | 153 | $192.76 | |
| 85048 | 1,146 | 1,089 | $177.01 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 430 | 348 | $109.82 |
| 90677 | 19 | 19 | $88.24 | |
| 90674 | 57 | 57 | $52.01 | |
| G0008 | Administration of influenza virus vaccine | 40 | 40 | $37.02 |
| 82746 | 249 | 243 | $24.44 | |
| 82607 | 79 | 76 | $7.06 | |
| 90662 | 36 | 35 | $5.72 | |
| 82947 | 22 | 22 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 13 | 13 | $0.00 |